These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15281188)

  • 41. A consideration of ethical issues in the design of clinical trials.
    Weymuller EA
    Am J Otolaryngol; 1996; 17(1):2-11. PubMed ID: 8801810
    [No Abstract]   [Full Text] [Related]  

  • 42. Beyond localism: a proposal for a National Research Review Board.
    Levine C; Caplan AL
    IRB; 1986; 8(2):7-9. PubMed ID: 11649751
    [No Abstract]   [Full Text] [Related]  

  • 43. Ethics lapses at Duke halt dozens of human experiments.
    Hilts PJ; Stolberg SG
    N Y Times Web; 1999 May; ():A26. PubMed ID: 11648115
    [No Abstract]   [Full Text] [Related]  

  • 44. Moral responsiveness in pediatric research ethics.
    Moeller CJ
    Am J Bioeth; 2003; 3(4):W1-W3. PubMed ID: 14744302
    [No Abstract]   [Full Text] [Related]  

  • 45. Panel pulls back report after NIH critique.
    Marshall E
    Science; 1998 Oct; 282(5390):857,859. PubMed ID: 9841427
    [No Abstract]   [Full Text] [Related]  

  • 46. Is It Ethical to Enroll Cognitively Impaired Adults in Research That Is More Than Minimal Risk With No Prospect of Benefit?
    Taylor HA; Kuwana E; Wilfond BS
    Am J Bioeth; 2015; 15(10):64-5. PubMed ID: 26479112
    [No Abstract]   [Full Text] [Related]  

  • 47. Continuing review of research involving human subjects: approach to the problem and remaining areas of concern.
    Gordon B; Prentice E
    IRB; 1997; 19(2):8-11. PubMed ID: 11655323
    [No Abstract]   [Full Text] [Related]  

  • 48. Rethinking risk in pediatric research.
    Glass KC; Binik A
    J Law Med Ethics; 2008; 36(3):567-76. PubMed ID: 18840250
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What conditions justify risky nontherapeutic or "no benefit" pediatric studies: a sliding scale analysis.
    Kopelman LM
    J Law Med Ethics; 2004; 32(4):749-58. PubMed ID: 15807363
    [No Abstract]   [Full Text] [Related]  

  • 50. Ethical issues in clinical research: the role of the research ethics committee.
    Aldridge HD; Walport MJ
    Br J Urol; 1995 Nov; 76 Suppl 2():23-8. PubMed ID: 8535750
    [No Abstract]   [Full Text] [Related]  

  • 51. Multicenter trials and subject eligibility: should local IRBs play a role?
    Freedman B
    IRB; 1994; 16(1-2):1-6. PubMed ID: 11652320
    [No Abstract]   [Full Text] [Related]  

  • 52. Ethical and legal considerations in dental caries research involving human subjects.
    Branson R
    J Dent Res; 1980 Jul; 59(Special Issue C):1214-364. PubMed ID: 11651755
    [No Abstract]   [Full Text] [Related]  

  • 53. Cognitively impaired subjects. American College of Physicians.
    Ann Intern Med; 1989 Nov; 111(10):843-8. PubMed ID: 2683918
    [No Abstract]   [Full Text] [Related]  

  • 54. Eyeing a project's ethics.
    Stone R
    Science; 1993 Mar; 259(5103):1820. PubMed ID: 11643255
    [No Abstract]   [Full Text] [Related]  

  • 55. Pediatric research: what is broken and what needs to be fixed?
    Lantos JD
    J Pediatr; 2004 Feb; 144(2):147-9. PubMed ID: 14760250
    [No Abstract]   [Full Text] [Related]  

  • 56. Ethics lobby forces rethink on growth hormones.
    Miller SK
    New Sci; 1992 Aug; 135(1834):9. PubMed ID: 11659508
    [No Abstract]   [Full Text] [Related]  

  • 57. Panel approves gene trial for "normals".
    Marshall E
    Science; 1997 Mar; 275(5306):1561. PubMed ID: 9072819
    [No Abstract]   [Full Text] [Related]  

  • 58. Federal regulations for fetal research: a case for reform.
    Fletcher JC; Ryan KJ
    Law Med Health Care; 1987; 15(3):126-38. PubMed ID: 3695575
    [No Abstract]   [Full Text] [Related]  

  • 59. Can children be enrolled in a placebo-controlled randomized clinical trial of synthetic growth hormone?
    Prentice ED; Antonson DL; Jameton A; Graber B; Sears T
    IRB; 1989; 11(1):6-10. PubMed ID: 11659085
    [No Abstract]   [Full Text] [Related]  

  • 60. Group benefit and protection of pediatric research subjects: Grimes v. Kennedy Krieger and the Lead Abatement Study.
    Kopelman LM
    Account Res; 2002; 9(3-4):177-92. PubMed ID: 12816126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.